We are the first to show that ERBB2‐amplified invasive lobular carcinomas similarly to ERBB2‐amplified NST breast carcinomas do exhibit concomitant CDK12/ERBB2 gene amplification. Here, CDK12 is linked to invasive lobular breast carcinoma.